The status of executions across the country has been in turmoil for more than a decade, ever since pharmaceutical companies began halting their delivery of the most widely used drugs for executions, reports The New York Times. State prison systems were left to create cocktails of the drugs they could still get their hands on, often relying on one sedative in particular, midazolam, to start the execution process.
But the lethal new formulations have led to legal
challenges across the country, with death row prisoners and their lawyers
arguing that the sedative now in use in about half a dozen states is
ineffective at its primary purpose: keeping prisoners from feeling pain as they
die.
The first full trial on the challenges to midazolam
played out this past week in Oklahoma, where a prisoner vomited and shook for several minutes after he was injected
with the sedative during an October execution. In the case before Judge Stephen
P. Friot of the U.S. District Court in Oklahoma City, a group of prisoners on
death row argued that the mix of drugs that awaits them in that state has the
potential to cause so much pain as to be “constitutionally intolerable.”
The U.S. Supreme Court allowed the use of midazolam in a 2015 ruling in the same
Oklahoma case, but the current trial has allowed for additional expert
testimony and presentations of detailed research about the real-world use of
the drug in execution chambers.
The case, one of several legal challenges to
execution drug protocols filed across the country, could have broad
implications for the 27 states with capital punishment, several of
which use midazolam.
The governors of three states have issued
moratoriums on the death penalty, and only 14 states where capital punishment
is currently legal have carried out an execution in the last decade, according to the Death Penalty Information Center.
The federal government executed 13 people under President Donald J. Trump, the first time
it carried out executions in 17 years, but the Biden administration has
since reintroduced a moratorium.
With a week full of excruciatingly detailed
testimony over how the human body may react to the drugs used in Oklahoma, the
case is an example of how the battle over the death penalty has shifted from
the legality of capital punishment to increasingly nuanced debates over how it is
carried out. The courts have repeatedly upheld the constitutionality of many
methods of execution, yet states have increasingly been unable to carry them
out as pressure from regulators, medical associations and groups that oppose
the death penalty have made it harder to obtain the lethal drugs.
“This is the
biggest issue in the realm of capital punishment: how we do executions,” said
Maria Kolar, an assistant professor at the Oklahoma City University School of
Law who studies the death penalty.
“We wouldn’t
just go drown someone or burn someone at the stake,” Ms. Kolar said. “But if
midazolam is not capable of maintaining that insensate state, we may well be
producing the same feeling in the person being executed.”
Oklahoma’s execution formula calls for an initial
dose of midazolam, which state prison officials say renders a prisoner
unconscious and impervious to pain. Once the drug takes effect, two other drugs
are administered to induce paralysis and then stop the heart — a process that
might be excruciating for someone who was not fully sedated.
Prison officials have argued that the
sedative is a “tried-and-true” way to make executions painless, and at
this week’s trial, each side called on doctors whose testimony bolstered its
case.
Dr. Ervin Yen, an anesthesiologist and former
Republican state senator now running as an independent for governor, testified
for Oklahoma after witnessing three recent executions. He said the mixture of
drugs currently in use allowed the state to execute people “in as humane a way
as possible,” according to The Oklahoman.
In contrast, Dr. Gail Van Norman, an anesthesiology
professor at the University of Washington who was called by the public
defenders representing the prisoners, said she was “virtually certain” that the
current drug combination had caused several men extreme pain, the newspaper reported.
In the 2015 ruling against the need for a
preliminary injunction to immediately halt use of midazolam, a majority of
Supreme Court justices also said that the prisoners challenging the sedative’s
use had failed to identify an alternate means of execution that would reduce
the likelihood of suffering.
The death row prisoners have now identified three
alternatives that they argue are readily available and preferable, including
two possible combinations using fentanyl, a powerful opioid, or scrapping
lethal injections altogether in favor of a firing squad.
At least two states that once used midazolam for
executions have stopped doing so in recent years. Florida began using a different drug after it was
unable to get more midazolam from its supplier, and Arizona did so as part of a settlement after a 2014 execution using
the drug lasted for nearly two hours, one of the longest in American
history.
Oklahoma’s history of killing prisoners has been
particularly plagued by errors.
In 2014, Clayton D. Lockett appeared to writhe in
pain after the medical staff failed to make sure that the midazolam sedative
flowed into his bloodstream; his execution was called off but he nonetheless
died 43 minutes later of a heart attack. In the state’s next execution, of
Charles F. Warner in 2015, officials mistakenly used the wrong drug to stop his
heart. The combination of mistakes led to a
six-year pause on executions in the state before the problematic execution of John Marion Grant in October.
Mr. Grant, who had been convicted of fatally stabbing
a prison cafeteria worker, appeared to vomit or regurgitate and, in the account
of reporters who witnessed his death, convulsed about two dozen times after
being injected with midazolam. At the time, the state’s prisons chief, Scott
Crow, said that the execution was “not pleasant to watch” but that he believed
it was nonetheless humane.
A ruling in favor of the prisoners would, at least
temporarily, block Oklahoma from carrying out additional executions using the
current combination of drugs, but would not halt other states from doing so.
About half a dozen states used midazolam as part of the lethal injection
mixture in their most recent execution, according to the Death Penalty Information Center.
If the plaintiffs are successful, Oklahoma would almost certainly appeal the
ruling, sending the case to an appellate court, and potentially to the Supreme
Court.
The state has executed three people with the use of
midazolam over the past three months, none of whom reacted similarly to Mr.
Grant. Lawyers for the plaintiffs said they expected that a ruling in
Oklahoma’s favor would lead the state to quickly schedule executions among the
40 people currently on death row.
The judge was not expected to issue a ruling for at
least a month, after an additional brief from lawyers on each side.
To read more CLICK HERE
No comments:
Post a Comment